| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.561 | 0.013 | 0.609 | GABA C receptor rho-3 antagonist | 0.609 0.006 DBMET00775 0.595 0.008 DBMET00776 | DBMET00775 | |
| 0.509 | 0.026 | 0.509 | 5 Hydroxytryptamine release stimulant | 0.453 0.035 DBMET00775 0.435 0.039 DBMET00776 | ||
| 0.432 | 0.01 | 0.432 | 5 Hydroxytryptamine antagonist | 0.224 0.029 DBMET00775 0.221 0.029 DBMET00776 | ||
| 0.416 | 0.009 | 0.416 | 5 Hydroxytryptamine 2 antagonist | 0.247 0.022 DBMET00775 0.259 0.02 DBMET00776 | ||
| 0.448 | 0.052 | 0.477 | 5 Hydroxytryptamine release inhibitor | 0.477 0.04 DBMET00775 0.436 0.058 DBMET00776 | DBMET00775 | |
| 0.383 | 0.008 | 0.383 | 5 Hydroxytryptamine 2A antagonist | 0.217 0.018 DBMET00775 0.228 0.017 DBMET00776 | ||
| 0.4 | 0.03 | 0.507 | Hypoxia-inducible factor 1 alpha inhibitor | 0.507 0.014 DBMET00775 0.463 0.018 DBMET00776 | DBMET00775 | |
| 0.405 | 0.073 | 0.471 | Histamine release inhibitor | 0.471 0.04 DBMET00775 0.437 0.057 DBMET00776 | DBMET00775 | |
| 0.331 | 0.006 | 0.331 | Dopamine D4 antagonist | 0.249 0.009 DBMET00775 0.215 0.011 DBMET00776 | ||
| 0.31 | 0.004 | 0.31 | 5 Hydroxytryptamine 3 antagonist | 0.106 0.016 DBMET00775 0.109 0.015 DBMET00776 | ||
| 0.305 | 0.009 | 0.305 | Alpha 2b adrenoreceptor antagonist | 0.266 0.012 DBMET00775 0.264 0.013 DBMET00776 | ||
| 0.298 | 0.012 | 0.298 | Dopamine antagonist | 0.275 0.013 DBMET00775 0.242 0.015 DBMET00776 | ||
| 0.336 | 0.051 | 0.364 | Aryl hydrocarbon receptor agonist | 0.364 0.045 DBMET00775 0.295 0.063 DBMET00776 | DBMET00775 | |
| 0.288 | 0.004 | 0.288 | 5 Hydroxytryptamine 3A agonist | 0.252 0.005 DBMET00775 0.249 0.005 DBMET00776 | ||
| 0.285 | 0.003 | 0.285 | 5 Hydroxytryptamine 3 agonist | 0.208 0.004 DBMET00775 0.195 0.004 DBMET00776 | ||
| 0.288 | 0.007 | 0.288 | Alpha 2a adrenoreceptor antagonist | 0.273 0.008 DBMET00775 0.266 0.008 DBMET00776 | ||
| 0.335 | 0.058 | 0.593 | Aldehyde oxidase inhibitor | 0.593 0.02 DBMET00775 0.506 0.032 DBMET00776 | DBMET00775 | |
| 0.387 | 0.112 | 0.387 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.286 | 0.015 | 0.286 | Toll-Like receptor 9 antagonist | 0.248 0.021 DBMET00775 0.233 0.024 DBMET00776 | ||
| 0.279 | 0.01 | 0.279 | 5 Hydroxytryptamine 2C antagonist | 0.15 0.027 DBMET00775 0.171 0.022 DBMET00776 | ||
| 0.268 | 0.005 | 0.268 | GABA receptor antagonist | 0.249 0.005 DBMET00775 0.186 0.007 DBMET00776 | ||
| 0.27 | 0.007 | 0.27 | 5 Hydroxytryptamine 1F antagonist | 0.146 0.017 DBMET00775 0.15 0.016 DBMET00776 | ||
| 0.302 | 0.042 | 0.302 | Psychostimulant | 0.252 0.058 DBMET00775 0.29 0.045 DBMET00776 | ||
| 0.258 | 0.01 | 0.258 | 5 Hydroxytryptamine agonist | 0.116 0.029 DBMET00775 0.116 0.029 DBMET00776 | ||
| 0.295 | 0.05 | 0.295 | HERG channel blocker | 0.145 0.136 DBMET00776 | ||
| 0.262 | 0.019 | 0.262 | Alpha adrenoreceptor antagonist | 0.215 0.025 DBMET00775 0.216 0.025 DBMET00776 | ||
| 0.246 | 0.004 | 0.246 | 5 Hydroxytryptamine 2 agonist | 0.124 0.006 DBMET00775 0.155 0.005 DBMET00776 | ||
| 0.246 | 0.008 | 0.349 | Dopamine D1 antagonist | 0.349 0.005 DBMET00775 0.333 0.005 DBMET00776 | DBMET00775 | |
| 0.249 | 0.011 | 0.249 | Alpha 2 adrenoreceptor antagonist | 0.214 0.016 DBMET00775 0.216 0.015 DBMET00776 | ||
| 0.248 | 0.013 | 0.248 | Dopamine D2 antagonist | 0.231 0.014 DBMET00775 0.204 0.016 DBMET00776 | ||
| 0.253 | 0.019 | 0.253 | 5 Hydroxytryptamine 2B antagonist | 0.144 0.043 DBMET00775 0.167 0.034 DBMET00776 | ||
| 0.279 | 0.045 | 0.279 | 5 Hydroxytryptamine 1E antagonist | 0.253 0.071 DBMET00775 0.247 0.078 DBMET00776 | ||
| 0.248 | 0.021 | 0.339 | NADPH oxidase inhibitor | 0.339 0.008 DBMET00775 0.304 0.012 DBMET00776 | DBMET00775 | |
| 0.332 | 0.107 | 0.332 | MAP kinase kinase 6 inhibitor | 0.252 0.188 DBMET00775 0.285 0.15 DBMET00776 | ||
| 0.225 | 0.009 | 0.309 | Protein kinase C zeta inhibitor | 0.309 0.005 DBMET00775 0.278 0.006 DBMET00776 | DBMET00775 | |
| 0.22 | 0.012 | 0.22 | Histamine H1 receptor antagonist | 0.122 0.032 DBMET00775 0.113 0.035 DBMET00776 | ||
| 0.228 | 0.027 | 0.228 | Ribosomal protein S6 kinase inhibitor | 0.197 0.038 DBMET00775 0.203 0.035 DBMET00776 | ||
| 0.26 | 0.063 | 0.26 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.207 | 0.011 | 0.207 | Protein kinase C mu inhibitor | 0.176 0.017 DBMET00775 0.182 0.015 DBMET00776 | ||
| 0.215 | 0.019 | 0.215 | Alpha 1 adrenoreceptor antagonist | 0.163 0.027 DBMET00775 0.168 0.026 DBMET00776 | ||
| 0.34 | 0.153 | 0.435 | Caspase 9 stimulant | 0.435 0.091 DBMET00775 0.43 0.094 DBMET00776 | DBMET00775 | |
| 0.2 | 0.018 | 0.2 | Alpha 2c adrenoreceptor antagonist | 0.183 0.021 DBMET00775 0.17 0.025 DBMET00776 | ||
| 0.192 | 0.011 | 0.192 | Dopamine D3 antagonist | 0.142 0.016 DBMET00775 0.127 0.019 DBMET00776 | ||
| 0.181 | 0.004 | 0.181 | 5 Hydroxytryptamine 3B antagonist | 0.068 0.009 DBMET00775 0.072 0.008 DBMET00776 | ||
| 0.236 | 0.061 | 0.254 | MAP kinase kinase 2 inhibitor | 0.254 0.052 DBMET00775 0.24 0.059 DBMET00776 | DBMET00775 | |
| 0.178 | 0.004 | 0.178 | Histamine H4 receptor antagonist | 0.077 0.009 DBMET00775 0.078 0.009 DBMET00776 | ||
| 0.175 | 0.004 | 0.175 | Histamine agonist | 0.07 0.019 DBMET00775 0.078 0.015 DBMET00776 | ||
| 0.176 | 0.007 | 0.176 | Acetylcholine M4 receptor antagonist | 0.098 0.029 DBMET00775 0.103 0.026 DBMET00776 | ||
| 0.213 | 0.044 | 0.213 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.187 | 0.018 | 0.187 | Alpha 1a adrenoreceptor antagonist | 0.123 0.029 DBMET00775 0.134 0.026 DBMET00776 | ||
| 0.243 | 0.075 | 0.243 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.206 0.149 DBMET00775 0.2 0.166 DBMET00776 | ||
| 0.231 | 0.063 | 0.263 | RNA-directed DNA polymerase inhibitor | 0.262 0.043 DBMET00775 0.263 0.043 DBMET00776 | DBMET00776 | |
| 0.169 | 0.004 | 0.169 | 5 Hydroxytryptamine 2C agonist | 0.105 0.007 DBMET00775 0.116 0.006 DBMET00776 | ||
| 0.194 | 0.032 | 0.205 | GABA C receptor rho-2 antagonist | 0.205 0.026 DBMET00775 0.194 0.032 DBMET00776 | DBMET00775 | |
| 0.166 | 0.005 | 0.166 | 5 Hydroxytryptamine 6 antagonist | 0.091 0.018 DBMET00775 0.091 0.018 DBMET00776 | ||
| 0.176 | 0.015 | 0.176 | 5 Hydroxytryptamine 7 antagonist | 0.074 0.035 DBMET00775 0.085 0.029 DBMET00776 | ||
| 0.233 | 0.075 | 0.233 | Potassium channel blocker | |||
| 0.165 | 0.013 | 0.165 | Alpha adrenoreceptor agonist | 0.124 0.021 DBMET00775 0.161 0.014 DBMET00776 | ||
| 0.159 | 0.007 | 0.159 | Protein kinase B alpha inhibitor | 0.12 0.018 DBMET00775 0.125 0.016 DBMET00776 | ||
| 0.156 | 0.005 | 0.156 | 5 Hydroxytryptamine 2A agonist | 0.133 0.007 DBMET00775 0.142 0.005 DBMET00776 | ||
| 0.175 | 0.026 | 0.175 | Antihistaminic | |||
| 0.151 | 0.005 | 0.151 | 5 Hydroxytryptamine 3A antagonist | 0.076 0.035 DBMET00775 0.082 0.03 DBMET00776 | ||
| 0.237 | 0.094 | 0.245 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.085 DBMET00775 0.216 0.123 DBMET00776 | DBMET00775 | |
| 0.206 | 0.065 | 0.208 | I kappa B kinase epsilon inhibitor | 0.188 0.081 DBMET00775 0.208 0.064 DBMET00776 | DBMET00776 | |
| 0.143 | 0.003 | 0.143 | 5 Hydroxytryptamine 2B agonist | 0.071 0.006 DBMET00775 0.082 0.005 DBMET00776 | ||
| 0.147 | 0.009 | 0.147 | GABA A receptor antagonist | 0.124 0.012 DBMET00775 0.091 0.018 DBMET00776 | ||
| 0.147 | 0.009 | 0.147 | Dopamine D4 agonist | 0.096 0.015 DBMET00775 0.076 0.021 DBMET00776 | ||
| 0.163 | 0.026 | 0.163 | Histamine antagonist | |||
| 0.139 | 0.002 | 0.139 | Histamine H4 receptor agonist | 0.049 0.004 DBMET00775 0.055 0.004 DBMET00776 | ||
| 0.15 | 0.025 | 0.236 | Beta glucuronidase inhibitor | 0.236 0.009 DBMET00775 0.21 0.012 DBMET00776 | DBMET00775 | |
| 0.207 | 0.082 | 0.252 | ErbB-1 antagonist | 0.195 0.095 DBMET00775 0.252 0.05 DBMET00776 | DBMET00776 | |
| 0.174 | 0.05 | 0.174 | Activin receptor-like kinase 2 inhibitor | 0.135 0.079 DBMET00775 0.132 0.083 DBMET00776 | ||
| 0.167 | 0.044 | 0.169 | Toll-Like receptor antagonist | 0.169 0.043 DBMET00775 0.16 0.049 DBMET00776 | DBMET00775 | |
| 0.134 | 0.012 | 0.134 | mTOR complex 2 inhibitor | 0.126 0.015 DBMET00775 0.119 0.018 DBMET00776 | ||
| 0.147 | 0.024 | 0.147 | 5 Hydroxytryptamine 1 antagonist | 0.083 0.045 DBMET00775 0.076 0.049 DBMET00776 | ||
| 0.239 | 0.117 | 0.239 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.222 0.133 DBMET00775 0.237 0.119 DBMET00776 | ||
| 0.155 | 0.034 | 0.155 | Antiadrenergic | 0.136 0.04 DBMET00775 0.145 0.037 DBMET00776 | ||
| 0.128 | 0.007 | 0.128 | Aryl hydrocarbon receptor antagonist | 0.114 0.009 DBMET00775 0.098 0.014 DBMET00776 | ||
| 0.219 | 0.098 | 0.276 | Superoxide dismutase inhibitor | 0.276 0.06 DBMET00775 0.23 0.089 DBMET00776 | DBMET00775 | |
| 0.211 | 0.091 | 0.22 | MAP-kinase-activated kinase 5 inhibitor | 0.22 0.081 DBMET00775 0.212 0.089 DBMET00776 | DBMET00775 | |
| 0.264 | 0.144 | 0.264 | Antiobesity | 0.217 0.19 DBMET00775 0.214 0.193 DBMET00776 | ||
| 0.153 | 0.034 | 0.153 | Adrenaline antagonist | 0.133 0.04 DBMET00775 0.143 0.037 DBMET00776 | ||
| 0.129 | 0.012 | 0.129 | Protein kinase B beta inhibitor | 0.095 0.029 DBMET00775 0.093 0.03 DBMET00776 | ||
| 0.255 | 0.141 | 0.255 | Calcium channel activator | 0.247 0.151 DBMET00776 | ||
| 0.133 | 0.018 | 0.133 | mTOR complex 1 inhibitor | 0.118 0.031 DBMET00775 0.119 0.03 DBMET00776 | ||
| 0.135 | 0.022 | 0.135 | 5 Hydroxytryptamine 1A antagonist | 0.088 0.037 DBMET00775 0.078 0.041 DBMET00776 | ||
| 0.127 | 0.019 | 0.145 | Cyclin B3 inhibitor | 0.145 0.015 DBMET00775 0.128 0.019 DBMET00776 | DBMET00775 | |
| 0.133 | 0.026 | 0.133 | Alpha 1b adrenoreceptor antagonist | 0.078 0.048 DBMET00775 0.104 0.034 DBMET00776 | ||
| 0.166 | 0.061 | 0.166 | Acetylcholine M1 receptor antagonist | 0.151 0.074 DBMET00775 0.158 0.067 DBMET00776 | ||
| 0.138 | 0.034 | 0.14 | Sphingosine 1-phosphate receptor 2 agonist | 0.14 0.032 DBMET00775 0.119 0.057 DBMET00776 | DBMET00775 | |
| 0.105 | 0.004 | 0.112 | Purinergic P2X4 antagonist | 0.112 0.004 DBMET00775 0.109 0.004 DBMET00776 | DBMET00775 | |
| 0.196 | 0.097 | 0.2 | Cyclic AMP phosphodiesterase inhibitor | 0.2 0.093 DBMET00775 0.191 0.101 DBMET00776 | DBMET00775 | |
| 0.138 | 0.04 | 0.154 | TRPA1 agonist | 0.154 0.029 DBMET00775 0.131 0.047 DBMET00776 | DBMET00775 | |
| 0.135 | 0.037 | 0.147 | Transcription factor STAT6 inhibitor | 0.147 0.025 DBMET00775 0.129 0.046 DBMET00776 | DBMET00775 | |
| 0.152 | 0.058 | 0.163 | MAP kinase kinase 4 inhibitor | 0.163 0.041 DBMET00775 0.16 0.044 DBMET00776 | DBMET00775 | |
| 0.125 | 0.034 | 0.125 | Phosphodiesterase 7B inhibitor | 0.086 0.076 DBMET00776 | ||
| 0.182 | 0.096 | 0.208 | Neurotrophic factor enhancer | 0.208 0.069 DBMET00775 0.208 0.069 DBMET00776 | DBMET00776 | |
| 0.1 | 0.015 | 0.1 | Alpha 2 adrenoreceptor agonist | 0.074 0.028 DBMET00775 0.086 0.02 DBMET00776 | ||
| 0.107 | 0.022 | 0.107 | Benzodiazepine agonist | |||
| 0.111 | 0.028 | 0.111 | Protein kinase B gamma inhibitor | 0.068 0.06 DBMET00775 0.065 0.064 DBMET00776 | ||
| 0.125 | 0.043 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 DBMET00775 0.116 0.053 DBMET00776 | DBMET00775 | |
| 0.106 | 0.024 | 0.106 | 5 Hydroxytryptamine uptake inhibitor | 0.061 0.045 DBMET00775 0.057 0.049 DBMET00776 | ||
| 0.163 | 0.082 | 0.163 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.176 | 0.096 | 0.241 | DNA methylase inhibitor | 0.199 0.08 DBMET00775 0.241 0.053 DBMET00776 | DBMET00776 | |
| 0.1 | 0.023 | 0.1 | Transforming growth factor beta 3 antagonist | 0.081 0.062 DBMET00775 0.086 0.048 DBMET00776 | ||
| 0.095 | 0.018 | 0.095 | Alpha 1 adrenoreceptor agonist | 0.062 0.034 DBMET00775 0.083 0.022 DBMET00776 | ||
| 0.164 | 0.087 | 0.194 | Amyloid beta precursor protein antagonist | 0.194 0.062 DBMET00775 0.177 0.075 DBMET00776 | DBMET00775 | |
| 0.082 | 0.006 | 0.082 | GABA B receptor antagonist | 0.082 0.006 DBMET00775 0.063 0.011 DBMET00776 | ||
| 0.077 | 0.004 | 0.077 | Alpha 1L adrenoreceptor agonist | 0.064 0.007 DBMET00775 0.066 0.006 DBMET00776 | ||
| 0.106 | 0.034 | 0.106 | MAP-kinase-activated kinase inhibitor | 0.089 0.05 DBMET00775 0.082 0.06 DBMET00776 | ||
| 0.16 | 0.094 | 0.244 | DNA methyltransferase I inhibitor | 0.194 0.072 DBMET00775 0.244 0.049 DBMET00776 | DBMET00776 | |
| 0.071 | 0.004 | 0.071 | Histamine H1 receptor agonist | 0.043 0.033 DBMET00775 0.045 0.028 DBMET00776 | ||
| 0.096 | 0.03 | 0.096 | MAP-kinase-activated kinase 2 inhibitor | 0.079 0.046 DBMET00775 0.072 0.055 DBMET00776 | ||
| 0.113 | 0.047 | 0.117 | GABA C receptor rho-1 antagonist | 0.117 0.043 DBMET00775 0.111 0.048 DBMET00776 | DBMET00775 | |
| 0.107 | 0.042 | 0.107 | Acetylcholine agonist | |||
| 0.078 | 0.014 | 0.078 | 5 Hydroxytryptamine 7 agonist | 0.063 0.027 DBMET00775 0.069 0.02 DBMET00776 | ||
| 0.101 | 0.04 | 0.101 | ALK inhibitor | 0.072 0.071 DBMET00775 0.086 0.052 DBMET00776 | ||
| 0.088 | 0.028 | 0.105 | MAP kinase kinase 7 inhibitor | 0.103 0.01 DBMET00775 0.105 0.009 DBMET00776 | DBMET00776 | |
| 0.089 | 0.029 | 0.089 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.102 | 0.043 | 0.102 | Pim-3 kinase inhibitor | 0.081 0.075 DBMET00775 0.081 0.074 DBMET00776 | ||
| 0.081 | 0.023 | 0.083 | Protease activated receptor antagonist | 0.083 0.022 DBMET00775 0.064 0.042 DBMET00776 | DBMET00775 | |
| 0.083 | 0.025 | 0.083 | Adrenaline uptake inhibitor | 0.061 0.043 DBMET00775 0.059 0.046 DBMET00776 | ||
| 0.093 | 0.037 | 0.093 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.055 | 0.004 | 0.055 | Imidazoline I1 receptor antagonist | 0.019 0.016 DBMET00775 0.025 0.01 DBMET00776 | ||
| 0.151 | 0.102 | 0.175 | Catenin beta inhibitor | 0.173 0.062 DBMET00775 0.175 0.059 DBMET00776 | DBMET00776 | |
| 0.101 | 0.052 | 0.101 | Protein kinase C delta inhibitor | 0.094 0.058 DBMET00775 0.09 0.063 DBMET00776 | ||
| 0.102 | 0.054 | 0.121 | Potassium channel (Ca-activated) activator | 0.117 0.043 DBMET00775 0.121 0.04 DBMET00776 | DBMET00776 | |
| 0.075 | 0.027 | 0.075 | Acetylcholine M5 receptor antagonist | 0.057 0.046 DBMET00775 0.058 0.044 DBMET00776 | ||
| 0.073 | 0.028 | 0.073 | Cyclin-dependent kinase 6 inhibitor | 0.061 0.04 DBMET00775 | ||
| 0.074 | 0.03 | 0.074 | MDM2 inhibitor | |||
| 0.143 | 0.1 | 0.164 | Interleukin 6 antagonist | 0.161 0.074 DBMET00775 0.164 0.071 DBMET00776 | DBMET00776 | |
| 0.075 | 0.033 | 0.075 | Alpha 1d adrenoreceptor antagonist | 0.052 0.047 DBMET00776 | ||
| 0.105 | 0.065 | 0.136 | Mediator release inhibitor | 0.136 0.036 DBMET00775 0.126 0.042 DBMET00776 | DBMET00775 | |
| 0.108 | 0.07 | 0.108 | Activin receptor-like kinase 4 inhibitor | |||
| 0.121 | 0.083 | 0.121 | Sodium channel blocker | |||
| 0.051 | 0.015 | 0.051 | Vascular adhesion protein 1 inhibitor | |||
| 0.087 | 0.051 | 0.11 | D-Ala-D-Ala ligase inhibitor | 0.11 0.019 DBMET00775 0.1 0.029 DBMET00776 | DBMET00775 | |
| 0.055 | 0.019 | 0.055 | Benzodiazepine antagonist | |||
| 0.044 | 0.009 | 0.053 | Protein kinase (CK2) beta inhibitor | 0.053 0.006 DBMET00775 0.05 0.007 DBMET00776 | DBMET00775 | |
| 0.062 | 0.029 | 0.062 | Glucosylceramidase inhibitor | 0.052 0.043 DBMET00775 0.053 0.041 DBMET00776 | ||
| 0.063 | 0.032 | 0.063 | Acetylcholine muscarinic agonist | |||
| 0.043 | 0.013 | 0.043 | Potassium channel small-conductance Ca-activated activator | |||
| 0.087 | 0.059 | 0.095 | Interleukin 5 antagonist | 0.095 0.047 DBMET00775 0.094 0.049 DBMET00776 | DBMET00775 | |
| 0.053 | 0.024 | 0.053 | Acetylcholine M1 receptor agonist | |||
| 0.059 | 0.031 | 0.059 | Pim-2 kinase inhibitor | |||
| 0.219 | 0.192 | 0.358 | 15-Lipoxygenase inhibitor | 0.358 0.095 DBMET00775 0.293 0.136 DBMET00776 | DBMET00775 | |
| 0.118 | 0.091 | 0.118 | Cytokine production inhibitor | |||
| 0.093 | 0.068 | 0.093 | Electrolyte absorption antagonist | |||
| 0.105 | 0.081 | 0.17 | Topoisomerase II inhibitor | 0.17 0.041 DBMET00775 0.153 0.048 DBMET00776 | DBMET00775 | |
| 0.101 | 0.077 | 0.111 | GABA C receptor antagonist | 0.111 0.063 DBMET00775 0.108 0.066 DBMET00776 | DBMET00775 | |
| 0.063 | 0.04 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.049 | 0.026 | 0.06 | Dopamine D5 antagonist | 0.06 0.019 DBMET00775 0.053 0.023 DBMET00776 | DBMET00775 | |
| 0.08 | 0.057 | 0.08 | Acetylcholine nicotinic agonist | |||
| 0.053 | 0.031 | 0.053 | Potassium channel (Inward rectifier) activator | |||
| 0.106 | 0.084 | 0.106 | Acetylcholine muscarinic antagonist | 0.098 0.094 DBMET00776 | ||
| 0.128 | 0.106 | 0.128 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.09 | 0.068 | 0.09 | Pim-1 kinase inhibitor | |||
| 0.068 | 0.046 | 0.068 | Acetylcholine M5 receptor agonist | |||
| 0.05 | 0.029 | 0.05 | Potassium channel (ATP-sensitive) activator | |||
| 0.068 | 0.047 | 0.068 | Protein kinase C alpha inhibitor | |||
| 0.045 | 0.025 | 0.045 | Nerve growth factor antagonist | |||
| 0.061 | 0.042 | 0.073 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.073 0.025 DBMET00775 0.064 0.036 DBMET00776 | DBMET00775 | |
| 0.112 | 0.094 | 0.112 | Sodium channel (voltage-gated) blocker | |||
| 0.067 | 0.049 | 0.067 | Toll-Like receptor 7 antagonist | |||
| 0.084 | 0.068 | 0.084 | Bromodomain-containing protein 2 inhibitor | |||
| 0.148 | 0.134 | 0.148 | Focal adhesion kinase 2 inhibitor | |||
| 0.101 | 0.086 | 0.101 | Acetylcholine release stimulant | |||
| 0.057 | 0.044 | 0.057 | Protein kinase C iota inhibitor | |||
| 0.03 | 0.017 | 0.03 | 5 Hydroxytryptamine 6 agonist | |||
| 0.045 | 0.033 | 0.045 | 5 Hydroxytryptamine 1A agonist | |||
| 0.109 | 0.098 | 0.109 | Nav1.2 sodium channel blocker | |||
| 0.051 | 0.041 | 0.051 | Heparanase inhibitor | |||
| 0.094 | 0.084 | 0.189 | Cystathionine beta-synthase inhibitor | 0.189 0.027 DBMET00775 0.161 0.036 DBMET00776 | DBMET00775 | |
| 0.139 | 0.13 | 0.168 | Neurotensin receptor agonist | 0.162 0.075 DBMET00775 0.168 0.065 DBMET00776 | DBMET00776 | |
| 0.066 | 0.057 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.055 DBMET00775 | ||
| 0.059 | 0.05 | 0.059 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.038 | 0.03 | 0.062 | Dopamine D5 agonist | 0.055 0.014 DBMET00775 0.062 0.011 DBMET00776 | DBMET00776 | |
| 0.048 | 0.04 | 0.048 | Sodium/calcium exchanger inhibitor | |||
| 0.054 | 0.047 | 0.054 | Phosphatidylinositol kinase inhibitor | 0.053 0.05 DBMET00775 | ||
| 0.085 | 0.078 | 0.085 | Check point kinase 2 inhibitor | |||
| 0.059 | 0.053 | 0.059 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.053 | 0.046 | 0.076 | Fatty acid synthase inhibitor | 0.076 0.021 DBMET00775 0.061 0.034 DBMET00776 | DBMET00775 | |
| 0.046 | 0.041 | 0.051 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.051 0.037 DBMET00775 | DBMET00775 | |
| 0.021 | 0.015 | 0.021 | Adenosine kinase inhibitor | |||
| 0.055 | 0.05 | 0.064 | Cyclin B1 inhibitor | 0.064 0.039 DBMET00775 0.058 0.046 DBMET00776 | DBMET00775 | |
| 0.012 | 0.007 | 0.012 | Imidazoline I2 receptor antagonist | |||
| 0.05 | 0.046 | 0.05 | Nicotinic neuronal receptor agonist | |||
| 0.093 | 0.089 | 0.093 | Protein kinase C gamma inhibitor | 0.093 0.09 DBMET00775 | ||
| 0.058 | 0.054 | 0.085 | Dopamine agonist | 0.085 0.034 DBMET00775 0.077 0.039 DBMET00776 | DBMET00775 | |
| 0.032 | 0.029 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.018 | 0.014 | 0.018 | Alpha 2c adrenoreceptor agonist | |||
| 0.166 | 0.163 | 0.192 | Nitric-oxide synthase stimulant | 0.192 0.102 DBMET00775 0.174 0.142 DBMET00776 | DBMET00775 | |
| 0.038 | 0.036 | 0.04 | CF transmembrane conductance regulator antagonist | 0.039 0.029 DBMET00775 0.04 0.027 DBMET00776 | DBMET00776 | |
| 0.05 | 0.049 | 0.05 | Dopamine uptake inhibitor | |||
| 0.049 | 0.048 | 0.056 | Cyclin B inhibitor | 0.056 0.037 DBMET00775 0.051 0.044 DBMET00776 | DBMET00775 | |
| 0.025 | 0.024 | 0.025 | Myristoyl transferase inhibitor | |||
| 0.065 | 0.064 | 0.065 | Phospholipase D inhibitor | |||
| 0.039 | 0.039 | 0.041 | DNA gyrase subunit A inhibitor | 0.04 0.036 DBMET00775 0.041 0.033 DBMET00776 | DBMET00776 | |
| 0.106 | 0.107 | 0.108 | Antibacterial (Helicobacter pylori) | 0.108 0.103 DBMET00775 | DBMET00775 | |
| 0.172 | 0.179 | 0.216 | Prostaglandin dehydrogenase inhibitor | 0.216 0.147 DBMET00775 | DBMET00775 | |
| 0.061 | 0.068 | 0.09 | Histone deacetylase SIRT1 stimulant | 0.09 0.035 DBMET00775 0.08 0.044 DBMET00776 | DBMET00775 | |
| 0.061 | 0.068 | 0.09 | Histone deacetylase stimulant | 0.09 0.035 DBMET00775 0.08 0.044 DBMET00776 | DBMET00775 | |
| 0.028 | 0.036 | 0.053 | Estrogen-related receptor beta antagonist | 0.053 0.005 DBMET00775 0.042 0.009 DBMET00776 | DBMET00775 | |
| 0.165 | 0.177 | 0.198 | DNA synthesis inhibitor | 0.198 0.127 DBMET00776 | DBMET00776 | |
| 0.061 | 0.073 | 0.114 | Topoisomerase II alpha inhibitor | 0.114 0.032 DBMET00775 0.096 0.042 DBMET00776 | DBMET00775 | |
| 0.044 | 0.058 | 0.054 | Cyclin B2 inhibitor | 0.054 0.041 DBMET00775 | DBMET00775 | |
| 0.174 | 0.189 | 0.204 | Tyrosine 3 hydroxylase inhibitor | 0.204 0.129 DBMET00775 0.201 0.134 DBMET00776 | DBMET00775 | |
| 0.066 | 0.081 | 0.11 | Estrogen receptor alpha antagonist | 0.11 0.022 DBMET00775 0.107 0.023 DBMET00776 | DBMET00775 | |
| 0.111 | 0.128 | 0.135 | Insulin secretagoues | 0.135 0.091 DBMET00775 | DBMET00775 | |
| 0.082 | 0.1 | 0.151 | Estrogen receptor beta antagonist | 0.151 0.015 DBMET00775 0.145 0.017 DBMET00776 | DBMET00775 | |
| 0.109 | 0.128 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 DBMET00776 | DBMET00776 | |
| 0.131 | 0.151 | 0.154 | Phospholipase C inhibitor | 0.154 0.098 DBMET00775 0.145 0.118 DBMET00776 | DBMET00775 | |
| 0.104 | 0.127 | 0.126 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.116 0.111 DBMET00775 0.126 0.099 DBMET00776 | DBMET00776 | |
| 0.061 | 0.084 | 0.079 | Platelet growth factor antagonist | 0.079 0.058 DBMET00776 | DBMET00776 | |
| 0.085 | 0.109 | 0.145 | MAO inhibitor | 0.145 0.063 DBMET00775 0.11 0.081 DBMET00776 | DBMET00775 | |
| 0.04 | 0.065 | 0.049 | Protein kinase C eta inhibitor | 0.049 0.046 DBMET00775 | DBMET00775 | |
| 0.03 | 0.056 | 0.052 | NMDA receptor subunit 3B antagonist | 0.045 0.029 DBMET00775 0.052 0.023 DBMET00776 | DBMET00776 | |
| 0.11 | 0.136 | 0.135 | Hexokinase inhibitor | 0.135 0.098 DBMET00776 | DBMET00776 | |
| 0.061 | 0.095 | 0.108 | MAO B inhibitor | 0.108 0.056 DBMET00775 0.082 0.073 DBMET00776 | DBMET00775 | |
| 0.063 | 0.099 | 0.071 | GABA B receptor agonist | 0.071 0.066 DBMET00776 | DBMET00776 | |
| 0.089 | 0.128 | 0.101 | Interleukin 8 antagonist | 0.101 0.094 DBMET00776 | DBMET00776 | |
| 0.174 | 0.216 | 0.252 | Caspase 3 stimulant | 0.252 0.11 DBMET00775 0.235 0.126 DBMET00776 | DBMET00775 | |
| 0.049 | 0.093 | 0.061 | Potassium channel large-conductance Ca-activated activator | 0.061 0.059 DBMET00776 | DBMET00776 | |
| 0.064 | 0.108 | 0.085 | Protein kinase (CK2) inhibitor | 0.085 0.078 DBMET00775 | DBMET00775 | |
| 0.065 | 0.109 | 0.1 | Urease inhibitor | 0.1 0.067 DBMET00775 | DBMET00775 | |
| 0.14 | 0.191 | 0.162 | DNA damaging | 0.162 0.155 DBMET00776 | DBMET00776 | |
| 0.087 | 0.142 | 0.124 | Alkaline phosphatase inhibitor | 0.124 0.081 DBMET00775 | DBMET00775 | |
| 0.063 | 0.121 | 0.087 | Breast cancer-resistant protein inhibitor | 0.087 0.07 DBMET00775 | DBMET00775 | |
| 0.124 | 0.182 | 0.153 | Death-associated protein kinase 2 inhibitor | 0.153 0.099 DBMET00775 | DBMET00775 | |
| 0.12 | 0.186 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.117 DBMET00775 | DBMET00775 | |
| 0.108 | 0.179 | 0.144 | CF transmembrane conductance regulator agonist | 0.144 0.088 DBMET00775 | DBMET00775 | |
| 0.083 | 0.157 | 0.154 | Interleukin 4 antagonist | 0.154 0.046 DBMET00775 0.135 0.065 DBMET00776 | DBMET00775 | |
| 0.048 | 0.127 | 0.098 | Macrophage migration inhibitory factor inhibitor | 0.098 0.036 DBMET00775 0.091 0.041 DBMET00776 | DBMET00775 | |
| 0.103 | 0.186 | 0.133 | Interferon gamma antagonist | 0.133 0.104 DBMET00776 | DBMET00776 | |
| 0.057 | 0.141 | 0.127 | Creatine kinase inhibitor | 0.12 0.041 DBMET00775 0.127 0.036 DBMET00776 | DBMET00776 | |
| 0.038 | 0.123 | 0.055 | Heat shock protein 90 beta antagonist | 0.055 0.049 DBMET00776 | DBMET00776 | |
| 0.064 | 0.152 | 0.105 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.105 0.096 DBMET00775 | DBMET00775 | |
| 0.095 | 0.185 | 0.142 | Platelet adhesion inhibitor | 0.142 0.115 DBMET00775 | DBMET00775 | |
| 0.093 | 0.185 | 0.149 | Pyruvate kinase inhibitor | 0.149 0.115 DBMET00775 | DBMET00775 | |
| 0.046 | 0.138 | 0.085 | Adrenaline agonist | 0.085 0.052 DBMET00776 | DBMET00776 | |
| 0.074 | 0.17 | 0.149 | Estrogen antagonist | 0.149 0.023 DBMET00775 0.142 0.027 DBMET00776 | DBMET00775 | |
| 0.134 | 0.234 | 0.238 | 12-Lipoxygenase inhibitor | 0.238 0.116 DBMET00775 0.193 0.159 DBMET00776 | DBMET00775 | |
| 0.081 | 0.184 | 0.125 | Mcl-1 antagonist | 0.125 0.118 DBMET00775 | DBMET00775 | |
| 0.092 | 0.206 | 0.135 | Dual specificity phosphatase inhibitor | 0.135 0.113 DBMET00775 | DBMET00775 | |
| 0.074 | 0.189 | 0.157 | Peroxidase inhibitor | 0.157 0.074 DBMET00775 | DBMET00775 | |
| 0.088 | 0.205 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 DBMET00776 | DBMET00776 | |
| 0.144 | 0.271 | 0.271 | Alpha-glucosidase inhibitor | 0.271 0.175 DBMET00775 | DBMET00775 | |
| 0.062 | 0.206 | 0.098 | DOPA decarboxylase inhibitor | 0.098 0.08 DBMET00775 | DBMET00775 | |
| 0.053 | 0.201 | 0.106 | Amylase inhibitor | 0.106 0.091 DBMET00775 | DBMET00775 | |
| 0.142 | 0.292 | 0.22 | Apoptosis antagonist | 0.22 0.156 DBMET00775 0.193 0.188 DBMET00776 | DBMET00775 | |
| 0.07 | 0.233 | 0.125 | Dual specificity phosphatase 3 inhibitor | 0.125 0.122 DBMET00775 | DBMET00775 | |
| 0.094 | 0.304 | 0.175 | Lipoxygenase inhibitor | 0.175 0.17 DBMET00775 | DBMET00775 | |
| 0.063 | 0.327 | 0.123 | NOS3 expression enhancer | 0.123 0.109 DBMET00775 | DBMET00775 | |
| 0.124 | 0.413 | 0.254 | Apoptosis agonist | 0.254 0.21 DBMET00775 | DBMET00775 | |
| 0.138 | 0.433 | 0.301 | Calcium channel L-type activator | 0.301 0.157 DBMET00776 | DBMET00776 | |
| 0.052 | 0.368 | 0.214 | Free radical scavenger | 0.214 0.086 DBMET00775 0.165 0.129 DBMET00776 | DBMET00775 | |
| 0.031 | 0.369 | 0.108 | Lipid peroxidase inhibitor | 0.108 0.107 DBMET00775 | DBMET00775 | |
| 0.047 | 0.431 | 0.199 | Antioxidant | 0.199 0.114 DBMET00775 | DBMET00775 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |